Sader, Helio S., Thomas R. Fritsche, and Ronald N. Jones. "Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates."Antimicrobial agents and chemotherapy 53.5 (2009): 2171-2175.
Al-Nawas, Bilal, and Pramod M. Shah. "Intracellular activity of ciprofloxacin and moxifloxacin, a new 8-methoxyquinolone, against methicillin-resistant Staphylococcus aureus." Journal of Antimicrobial Chemotherapy 41.6 (1998): 655-658.
Grim, Shellee A., et al. "Trimethoprim‐Sulfamethoxazole as a Viable Treatment Option for Infections Caused by Methicillin‐Resistant Staphylococcus aureus."Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 25.2 (2005): 253-264.
Parish, Daniel, and Noah Scheinfeld. "Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection." Current opinion in investigational drugs (London, England: 2000) 9.2 (2008): 201-209.
Murthy, Bindu, and Anne Schmitt-Hoffmann. "Pharmacokinetics and pharmacodynamics of ceftobiprole, an anti-MRSA cephalosporin with broad-spectrum activity." Clinical pharmacokinetics 47.1 (2008): 21-33.
Leighton, Anton, et al. "Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers." Antimicrobial agents and chemotherapy 48.3 (2004): 940-945.
McKay, Geoffrey A., et al. "Time–kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium." Journal of antimicrobial chemotherapy 63.6 (2009): 1191-1199.
Higgins, Deborah L., et al. "Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus." Antimicrobial agents and chemotherapy 49.3 (2005): 1127-1134.
Wu, Wen-Shiann, et al. "Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin-resistant Staphylococcus aureus." Journal of Microbiology, Immunology and Infection 46.2 (2013): 89-95.
Nakazawa, Hiroaki, et al. "Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin." Journal of infection and chemotherapy 9.4 (2003): 304-309.
French, G. L. "Bactericidal agents in the treatment of MRSA infections—the potential role of daptomycin." Journal of Antimicrobial Chemotherapy 58.6 (2006): 1107-1117.
Livermore, David M. "Tigecycline: what is it, and where should it be used?."Journal of Antimicrobial Chemotherapy 56.4 (2005): 611-614.
Watkins, Richard R., Tracy L. Lemonovich, and Thomas M. File Jr. "An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy." Core evidence 7 (2012): 131.
Drew, Richard H., et al. "Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin–dalfopristin in patients intolerant of or failing prior therapy." Journal of Antimicrobial Chemotherapy 46.5 (2000): 775-784.